Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06635434 · ClinicalTrials.gov registry record · Early Phase 1

An English/Spanish Mobile Augmented Reality Pain Assessment App for Hispanic/Latino Pediatric Cancer Patients

A Early Phase 1 study of Pain and Pediatric Cancer, sponsored by ALTality.

Active
Registry status
Early Phase 1
Development phase
16
Enrollment target
1
Study location

NCT06635434 is a Early Phase 1 study of Pain and Pediatric Cancer that is active but no longer recruiting, run by ALTality. The registered enrollment target is 16 participants, below the 304-participant average among 374 other Pain trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06635434, a Early Phase 1 study of Pain and Pediatric Cancer, is active but no longer recruiting, sponsored by ALTality.

ACTIVE NOT RECRUITING
Registry status
Early Phase 1
Development phase
16 participants
Enrollment target
1
Study location

Study Summary

In this SBIR, ALTality, Inc. ("SpellBound") will assess the feasibility of a dual English/Spanish language augmented reality(AR)-enabled tool for assessing inpatient postoperative pain/nausea/vomiting in Hispanic/Latino children and adolescents with cancer in collaboration with bilingual Spanish-speaking anesthesiologists at the MD Anderson Cancer Center. If successful, the AR app will be an immediately implementable and commercially viable method of providing Hispanic/Latino pediatric cancer patients with limited English proficiency an adjunctive tool to overcome infrastructural barriers to receiving translation services in acute care settings that put them at higher risk of under and/or overtreatment of pain by prescription opioids and future prescription opioid dependency and misuse, at no cost to them or their families.

Conditions Studied

Pain Pediatric Cancer

Interventions

  • DEVICE AR Pain assessment

Study Locations (1)

Texas

  • MD Anderson Cancer Center - Houston

Trial Details

FieldValue
Enrollment Target 16 participants
Start Date 2023-02-05
Est. Completion 2024-11-30
Phase Early Phase 1

Sponsor

ALTality

1 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT06635434

The ClinicalTrials.gov registry entry for NCT06635434 describes a study currently listed as active not recruiting, categorized as Early Phase 1. The registered enrollment target is 16 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 304-participant average among 374 other Pain trials with a reported enrollment target (95% lower). The listed sponsor is ALTality, which has 1 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Pain appearing as the primary indexed condition, and to 1 intervention - of which AR Pain assessment is the first listed.

NCT06635434 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.

Frequently Asked Questions

What is clinical trial NCT06635434 about?

NCT06635434 is a clinical study titled "An English/Spanish Mobile Augmented Reality Pain Assessment App for Hispanic/Latino Pediatric Cancer Patients". In this SBIR, ALTality, Inc. ("SpellBound") will assess the feasibility of a dual English/Spanish language augmented reality(AR)-enabled tool for assessing inpatient postoperative pain/nausea/vomiting in Hispanic/Latino children and adolescents with cancer in collaboration with bilingual Spanish-spe...

What is the current status of trial NCT06635434?

This trial is currently active not recruiting. It is a Early Phase 1 study. The enrollment target is 16 participants. The study started on 2023-02-05. Estimated completion is 2024-11-30.

What conditions does trial NCT06635434 study?

This clinical trial studies the following conditions: Pain, Pediatric Cancer.

What interventions are being tested in trial NCT06635434?

The interventions under investigation include: AR Pain assessment (DEVICE).

Who is sponsoring clinical trial NCT06635434?

This trial is sponsored by ALTality, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06635434 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Pain

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Pain

All registered trials for this condition

Pediatric Cancer

All registered trials for this condition

Texas

All trials with a study site in Texas

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.